Enter the first few characters of Company and click 'Go'
Annual Financial Results of Jenburkt Pharmaceuticals Ltd.(Figures in Rs crores)
|
|
Mar 31, 2023 |
Mar 31, 2022 |
Mar 31, 2021 |
Mar 31, 2020 |
Mar 31, 2019 |
Net Sales / Income |
136.75 |
123.98 |
109.29 |
118.89 |
122.64 |
Other Income |
5.12 |
4.95 |
4.31 |
4.22 |
3.41 |
Net Profit/Loss |
24.61 |
22.30 |
16.50 |
14.87 |
19.80 |
Raw Material |
11.12 |
11.74 |
6.78 |
9.65 |
11.84 |
Power And Fuel |
0 |
0 |
0 |
0 |
0 |
Employee Expenses |
38.81 |
36.49 |
32.38 |
36.51 |
31.20 |
Excise |
|
|
|
|
|
Admin And Selling Expenses |
0 |
0 |
0 |
0 |
0 |
Research And Devlopment Expenses |
0 |
0 |
0 |
0 |
0 |
Expenses Capitalised |
0 |
0 |
0 |
0 |
0 |
Other Expenses |
55.12 |
50.78 |
47.11 |
53.47 |
57.13 |
Provisions Made |
0 |
0 |
0 |
0 |
0 |
Interest |
0.37 |
0.43 |
0.47 |
0.53 |
0.39 |
Gross Profit |
35.12 |
31.77 |
23.68 |
23.44 |
27.99 |
Depreciation |
2.26 |
1.90 |
2.04 |
2.30 |
1.35 |
Taxation |
8.26 |
7.57 |
5.14 |
6.27 |
6.84 |
Extra Ordinary Item |
0 |
0 |
0 |
0 |
0 |
Prior Year Adjustments |
0 |
0 |
0 |
0 |
0 |
Equity Capital |
4.41 |
4.59 |
4.59 |
4.59 |
4.59 |
Equity Dividend Rate |
0 |
0 |
0 |
0 |
0 |
Agg.Of Non-Prom. Shares (in lacs) |
0 |
0 |
0 |
0 |
0 |
Agg.Of Non PromotoHolding (%) |
0 |
0 |
0 |
0 |
0 |
EPS (in Rs.) |
55.76 |
48.58 |
35.96 |
32.40 |
43.14 |
|
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article